1. Home
  2. TRML vs BWMX Comparison

TRML vs BWMX Comparison

Compare TRML & BWMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRML
  • BWMX
  • Stock Information
  • Founded
  • TRML 2021
  • BWMX 1995
  • Country
  • TRML United States
  • BWMX Mexico
  • Employees
  • TRML N/A
  • BWMX N/A
  • Industry
  • TRML Biotechnology: Pharmaceutical Preparations
  • BWMX Catalog/Specialty Distribution
  • Sector
  • TRML Health Care
  • BWMX Consumer Discretionary
  • Exchange
  • TRML Nasdaq
  • BWMX Nasdaq
  • Market Cap
  • TRML 509.8M
  • BWMX 447.8M
  • IPO Year
  • TRML N/A
  • BWMX N/A
  • Fundamental
  • Price
  • TRML $13.84
  • BWMX $11.37
  • Analyst Decision
  • TRML Strong Buy
  • BWMX Strong Buy
  • Analyst Count
  • TRML 6
  • BWMX 1
  • Target Price
  • TRML $45.20
  • BWMX $22.50
  • AVG Volume (30 Days)
  • TRML 360.6K
  • BWMX 16.3K
  • Earning Date
  • TRML 03-13-2025
  • BWMX 04-24-2025
  • Dividend Yield
  • TRML N/A
  • BWMX 12.24%
  • EPS Growth
  • TRML N/A
  • BWMX N/A
  • EPS
  • TRML N/A
  • BWMX 0.92
  • Revenue
  • TRML N/A
  • BWMX $676,704,288.00
  • Revenue This Year
  • TRML $363.93
  • BWMX $8.79
  • Revenue Next Year
  • TRML N/A
  • BWMX $6.14
  • P/E Ratio
  • TRML N/A
  • BWMX $12.42
  • Revenue Growth
  • TRML N/A
  • BWMX 8.39
  • 52 Week Low
  • TRML $11.87
  • BWMX $10.05
  • 52 Week High
  • TRML $29.79
  • BWMX $20.36
  • Technical
  • Relative Strength Index (RSI)
  • TRML 37.41
  • BWMX 47.52
  • Support Level
  • TRML $16.39
  • BWMX $11.23
  • Resistance Level
  • TRML $17.36
  • BWMX $11.87
  • Average True Range (ATR)
  • TRML 1.03
  • BWMX 0.39
  • MACD
  • TRML -0.35
  • BWMX -0.02
  • Stochastic Oscillator
  • TRML 1.72
  • BWMX 22.69

About TRML Tourmaline Bio Inc.

Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.

About BWMX Betterware de Mexico S.A.P.I. de C.V.

Betterware de Mexico SAPI de CV is a direct-to-consumer selling company. The company operates through two business segments: the home organization products (Betterware segment or BWM segment) and the beauty and personal care products (B and PC) (JAFRA segment). The Betterware's segment is divided into different categories based on the type of products it sells and includes, kitchen and food preservation, home solutions, bathroom, laundry & cleaning, tech and mobility, and bedroom and wellness products. The JAFRA's segment is divided into fragrance, color, skincare, and toiletries products. The company generates a majority of its revenue from the Beauty and personal care (B&PC) (JAFRA segment). Geographically, key revenue for the company is derived from Mexico.

Share on Social Networks: